CHD1L and gastric cancer: Recently, CHD1L has also been reported as a novel biomarker for patients' prognosis in several types of solid tumor, including breast cancer [8], gastric cancer [9], colorectal cancer [10], bladder cancer [11] and ovarian cancer [12].